Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2970]

AACR 2018: Boosting T cell “memory” may result in longer-lasting and effective responses for patients treated with checkpoint blockade immunotherapies

AACR 2018: Boosting T cell “memory” may result in longer-lasting and effective responses for patients treated with...

AACR 2018: Updated OS data for olaparib in gBRCA-Mutated HER2 negative metastatic breast cancer

AACR 2018: Updated OS data for olaparib in gBRCA-Mutated HER2 negative metastatic breast cancer

Better identification of patients at risk for oesophageal cancer laser microscopy technique

Better identification of patients at risk for oesophageal cancer laser microscopy technique

AACR 2018: First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple cancers

AACR 2018: First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple...

'Killer' kidney cancers identified by studying their evolution

'Killer' kidney cancers identified by studying their evolution

Alectinib provides longer symptom improvement than crizotinib in ALK-positive lung cancer

Alectinib provides longer symptom improvement than crizotinib in ALK-positive lung cancer

Further evidence that immunotherapy provides a long-term survival benefit for lung cancer patients

Further evidence that immunotherapy provides a long-term survival benefit for lung cancer patients

Training the immune system to fight ovarian cancer

Training the immune system to fight ovarian cancer

Nanoparticles for lung cancer pass next test

Nanoparticles for lung cancer pass next test

Study finds how fat tissue shunts energy to tumours

Study finds how fat tissue shunts energy to tumours

More from ecancer